Literature DB >> 26381549

Cost-effectiveness of Occupational Therapy in Older People: Systematic Review of Randomized Controlled Trials.

Hirofumi Nagayama1,2, Kounosuke Tomori1, Kanta Ohno3, Kayoko Takahashi4, Keita Yamauchi2.   

Abstract

A systematic review of the cost-effectiveness of occupational therapy for older people was conducted. MEDLINE, CINAHL, Web of Science, PsycINFO, Cochrane Library, OT seeker and unpublished trials registers were searched. Reference lists of all potentially eligible studies were searched with no language restrictions. We included trial-based full economic evaluations that considered both costs and outcomes in occupational therapy for older people compared with standard care (i.e. other therapy) or no intervention. We reviewed each trial for methodological quality using the Cochrane risk of bias tool and assessed the quality of economic evaluations using a Drummond checklist. In the results of this review, we included five eligible studies (1-5) that were randomized controlled trials with high-quality economic evaluation. Two studies were full economic evaluations of interventions for fall prevention (1 and 2); two studies were full economic evaluations of preventive occupational therapy interventions (3 and 4; one was a comparison of an occupational therapy group with a social work group); one study was a full economic evaluation of occupational therapy for individuals with dementia (5). Two of the studies (one was preventive occupational therapy [3] and the other was occupational therapy for dementia [5]) found a significant effect and confirmed the cost-effectiveness of occupational therapy for older people compared with the control group. These studies found that occupational therapy for older people was clinically effective and cost-effective in comparison with standard care or other therapies. With reference to their clinical implication, these intervention studies (using a client-centred approach) suggested potentially cost-effective means to motivate clients to maintain their own health. However, this review has limitations because of the high heterogeneity of the reviewed studies on full economic evaluations of occupational therapy for older people. Future studies on the cost-effectiveness of occupational therapy in older people are strongly warranted.
Copyright © 2015 John Wiley & Sons, Ltd. Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cost-effectiveness of occupational therapy; older people; systematic review

Mesh:

Year:  2015        PMID: 26381549     DOI: 10.1002/oti.1408

Source DB:  PubMed          Journal:  Occup Ther Int        ISSN: 0966-7903            Impact factor:   1.448


  4 in total

1.  The Upside of Negative Emotions: How Do Older Adults From Different Cultures Challenge Their Self-Growth During the COVID-19 Pandemic?

Authors:  Sofia von Humboldt; Neyda Ma Mendoza-Ruvalcaba; Elva Dolores Arias-Merino; José Alberto Ribeiro-Gonçalves; Emilia Cabras; Gail Low; Isabel Leal
Journal:  Front Psychol       Date:  2022-05-09

2.  Occupational Therapy, Self-Efficacy, Well-Being in Older Adults Living in Residential Care Facilities: A Randomized Clinical Trial.

Authors:  Abel Toledano-González; Teresa Labajos-Manzanares; Dulce María Romero-Ayuso
Journal:  Front Psychol       Date:  2018-08-07

Review 3.  Occupational Therapy and the Use of Technology on Older Adult Fall Prevention: A Scoping Review.

Authors:  María Del Carmen Miranda-Duro; Laura Nieto-Riveiro; Patricia Concheiro-Moscoso; Betania Groba; Thais Pousada; Nereida Canosa; Javier Pereira
Journal:  Int J Environ Res Public Health       Date:  2021-01-15       Impact factor: 3.390

4.  Effectiveness and Cost-Effectiveness of Occupation-Based Occupational Therapy Using the Aid for Decision Making in Occupation Choice (ADOC) for Older Residents: Pilot Cluster Randomized Controlled Trial.

Authors:  Hirofumi Nagayama; Kounosuke Tomori; Kanta Ohno; Kayoko Takahashi; Kakuya Ogahara; Tatsunori Sawada; Sei Uezu; Ryutaro Nagatani; Keita Yamauchi
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.